Mario Rotondi

Dr. Mario Rotondi

Department of Internal Medicine and Therapeutics, University of Pavia, 27100 Pavia, Italy

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2020 in Cytokine & Growth Factor Reviews
Verified
Journal Article
Closed access
FCFrancesca Coperchini
Francesca Coperchini
LCLuca Chiovato
Luca Chiovato
LCLaura Croce
Laura Croce
FMFlavia Magri
Flavia Magri
MRMario Rotondi
Mario Rotondi

24 May 2012 in Stem Cells
Verified
Journal Article
Open access
PDF file
MAMaria Lucia Angelotti
Maria Lucia Angelotti
ERElisa Ronconi
Elisa Ronconi
LBLara Ballerini
Lara Ballerini
Anna Julie PeiredAnna Julie Peired
Anna Julie Peired
BMBenedetta Mazzinghi
Benedetta Mazzinghi
PRPaola Romagnani
Paola Romagnani
Recent studies implicated the existence in adult human kidney of a population of renal progenitors with the potential to regenerate glomerular as well as tubular epithelial cells and characterized by coexpression of surface markers CD133 and CD24. Here, we demonstrate that CD133+CD24+ renal progenitors can be distinguished in distinct subpopulations from normal human kidneys based on the surface expression of vascular cell adhesion molecule 1, also known as CD106. CD133+CD24+CD106+ cells were localized at the urinary pole of Bowman's capsule, while a distinct population of scattered CD133+CD24+CD106− cells was localized in the proximal tubule as well as in the distal convoluted tubule. CD133+CD24+CD106+ cells exhibited a high proliferative rate and could differentiate toward the podocyte as well as the tubular lineage. By contrast, CD133+CD24+CD106− cells showed a lower proliferative capacity and displayed a committed phenotype toward the tubular lineage. Both CD133+CD24+CD106+ and CD133+CD24+CD106− cells showed higher resistance to injurious agents in comparison to all other differentiated cells of the kidney. Once injected in SCID mice affected by acute tubular injury, both of these populations displayed the capacity to engraft within the kidney, generate novel tubular cells, and improve renal function. These properties were not shared by other tubular cells of the adult kidney. Finally, CD133+CD24+CD106− cells proliferated upon tubular injury, becoming the predominating part of the regenerating epithelium in patients with acute or chronic tubular damage. These data suggest that CD133+CD24+CD106− cells represent tubular‐committed progenitors that display resistance to apoptotic stimuli and exert regenerative potential for injured tubular tissue. STEM CELLS2012;30:1714–1725

1 October 2014 in European Journal of Endocrinology
Verified
Journal Article
Closed access
PDF file
FSFerruccio Santini
Ferruccio Santini
PMPAOLO MARZULLO
PAOLO MARZULLO
MRMario Rotondi
Mario Rotondi
GCGiovanni Ceccarini
Giovanni Ceccarini
LPLoredana Pagano
Loredana Pagano
BBBernadette Biondi
Bernadette Biondi
Obesity and thyroid diseases are common disorders in the general population and they frequently occur in single individuals. Alongside a chance association, a direct relationship between ‘thyroid and obesity’ has been hypothesized. Thyroid hormone is an important determinant of energy expenditure and contributes to appetite regulation, while hormones and cytokines from the adipose tissue act on the CNS to inform on the quantity of energy stores. A continuous interaction between the thyroid hormone and regulatory mechanisms localized in adipose tissue and brain is important for human body weight control and maintenance of optimal energy balance. Whether obesity has a pathogenic role in thyroid disease remains largely a matter of investigation. This review highlights the complexity in the identification of thyroid hormone deficiency in obese patients. Regardless of the importance of treating subclinical and overt hypothyroidism, at present there is no evidence to recommend pharmacological correction of the isolated hyperthyrotropinemia often encountered in obese patients. While thyroid hormones are not indicated as anti-obesity drugs, preclinical studies suggest that thyromimetic drugs, by targeting selected receptors, might be useful in the treatment of obesity and dyslipidemia.

11 November 2016 in Journal of Endocrinological Investigation
Verified
Journal Article
Closed access
PDF file
FCF. Coperchini
F. Coperchini
OAO. Awwad
O. Awwad
MRMario Rotondi
Mario Rotondi
FSFerruccio Santini
Ferruccio Santini
MIM. Imbriani
M. Imbriani
LCL. Chiovato
L. Chiovato

1 April 2021 in Cytokine & Growth Factor Reviews
Verified
Journal Article
Closed access
FCFrancesca Coperchini
Francesca Coperchini
LCLuca Chiovato
Luca Chiovato
GRGianluca Ricci
Gianluca Ricci
LCLaura Croce
Laura Croce
FMFlavia Magri
Flavia Magri
MRMario Rotondi
Mario Rotondi

26 April 2021 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
FCFrancesca Coperchini
Francesca Coperchini
LCLuca Chiovato
Luca Chiovato
MRMario Rotondi
Mario Rotondi
SARS-COV-2 virus is responsible for the ongoing devastating pandemic. Since the early phase of the pandemic, the “cytokine-storm” appeared a peculiar aspect of SARS-COV-2 infection which, at least in the severe cases, is responsible for respiratory treat damage and subsequent multi-organ failure. The efforts made in the last few months elucidated that the cytokine-storm results from a complex network involving cytokines/chemokines/infiltrating-immune-cells which orchestrate the aberrant immune response in COVID-19. Clinical and experimental studies aimed at depicting a potential “immune signature” of SARS-COV-2, identified three main “actors,” namely the cytokine IL-6, the chemokine CXCL10 and the infiltrating immune cell type macrophages. Although other cytokines, chemokines and infiltrating immune cells are deeply involved and their role should not be neglected, based on currently available data, IL-6, CXCL10, and infiltrating macrophages could be considered prototype factors representing each component of the immune system. It rapidly became clear that a strong and continuous interplay among the three components of the immune response is mandatory in order to produce a severe clinical course of the disease. Indeed, while IL-6, CXCL10 and macrophages alone would not be able to fully drive the onset and maintenance of the cytokine-storm, the establishment of a IL-6/CXCL10/macrophages axis is crucial in driving the sequence of events characterizing this condition. The present review is specifically aimed at overviewing current evidences provided by both in vitro and in vivo studies addressing the issue of the interplay among IL-6, CXCL10 and macrophages in the onset and progression of cytokine storm. SARS-COV-2 infection and the “cytokine storm.”